Kruczynski A - Search Results

1

Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.

Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D. Pourroy B, et al. Among authors: kruczynski a. Cancer Res. 2006 Mar 15;66(6):3256-63. doi: 10.1158/0008-5472.CAN-05-3885. Cancer Res. 2006. PMID: 16540678 Free article.

2

Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.

Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M. Jean-Decoster C, et al. Among authors: kruczynski a. Anticancer Drugs. 1999 Jul;10(6):537-43. Anticancer Drugs. 1999. PMID: 10885901

3

Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway.

Pourroy B, Carré M, Honoré S, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D. Pourroy B, et al. Among authors: kruczynski a. Mol Pharmacol. 2004 Sep;66(3):580-91. doi: 10.1124/mol.66.3.. Mol Pharmacol. 2004. PMID: 15322250

4

Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine.

Estève MA, Carré M, Bourgarel-Rey V, Kruczynski A, Raspaglio G, Ferlini C, Braguer D. Estève MA, et al. Among authors: kruczynski a. Mol Cancer Ther. 2006 Nov;5(11):2824-33. doi: 10.1158/1535-7163.MCT-06-0277. Mol Cancer Ther. 2006. PMID: 17121929

5

Antitumor activity of vinflunine: effector pathways and potential for synergies.

Braguer D, Barret JM, McDaid H, Kruczynski A. Braguer D, et al. Among authors: kruczynski a. Semin Oncol. 2008 Jun;35(3 Suppl 3):S13-21. doi: 10.1053/j.seminoncol.2008.01.011. Semin Oncol. 2008. PMID: 18538174 Review.

6

Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites.

Honoré S, Pagano A, Gauthier G, Bourgarel-Rey V, Verdier-Pinard P, Civiletti K, Kruczynski A, Braguer D. Honoré S, et al. Among authors: kruczynski a. Mol Cancer Ther. 2008 Jul;7(7):2080-9. doi: 10.1158/1535-7163.MCT-08-0156. Mol Cancer Ther. 2008. PMID: 18645018

7

Anti-migratory effect of vinflunine in endothelial and glioblastoma cells is associated with changes in EB1 C-terminal detyrosinated/tyrosinated status.

Rovini A, Gauthier G, Bergès R, Kruczynski A, Braguer D, Honoré S. Rovini A, et al. Among authors: kruczynski a. PLoS One. 2013 Jun 4;8(6):e65694. doi: 10.1371/journal.pone.0065694. Print 2013. PLoS One. 2013. PMID: 23750272 Free PMC article.

8

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

Berges R, Baeza-Kallee N, Tabouret E, Chinot O, Petit M, Kruczynski A, Figarella-Branger D, Honore S, Braguer D. Berges R, et al. Among authors: kruczynski a. Oncotarget. 2014 Dec 30;5(24):12769-87. doi: 10.18632/oncotarget.2646. Oncotarget. 2014. PMID: 25473893 Free PMC article.

9

Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.

Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT. Kruczynski A, et al. Biochem Pharmacol. 1998 Mar 1;55(5):635-48. doi: 10.1016/s0006-2952(97)00505-4. Biochem Pharmacol. 1998. PMID: 9515574

10

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts.

Hill BT, Fiebig HH, Waud WR, Poupon MF, Colpaert F, Kruczynski A. Hill BT, et al. Among authors: kruczynski a. Eur J Cancer. 1999 Mar;35(3):512-20. doi: 10.1016/s0959-8049(98)00416-x. Eur J Cancer. 1999. PMID: 10448309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters